Sichuan Kelun Pharmaceutical Co (SZSE:002422) Total Assets : ¥37,676 Mil (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Sichuan Kelun Pharmaceutical Co Total Assets?

Sichuan Kelun Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 was ¥37,676 Mil.

During the past 12 months, Sichuan Kelun Pharmaceutical Co's average Total Assets Growth Rate was 4.40% per year. During the past 3 years, the average Total Assets Growth Rate was 1.30% per year. During the past 5 years, the average Total Assets Growth Rate was 1.20% per year. During the past 10 years, the average Total Assets Growth Rate was 6.10% per year.

During the past 13 years, Sichuan Kelun Pharmaceutical Co's highest 3-Year average Total Assets Growth Rate was 64.60%. The lowest was -0.20%. And the median was 12.00%.

Total Assets is connected with ROA %. Sichuan Kelun Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2024 was 11.07%. Total Assets is also linked to Revenue through Asset Turnover. Sichuan Kelun Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.17.

Sichuan Kelun Pharmaceutical Co Total Assets Historical Data

The historical data trend for Sichuan Kelun Pharmaceutical Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sichuan Kelun Pharmaceutical Co Total Assets Chart

Sichuan Kelun Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

31,485.37

32,009.62

31,539.91

34,205.98

36,454.90

Sichuan Kelun Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															36,105.51	34,903.04	35,959.92	36,454.90	37,676.46

Sichuan Kelun Pharmaceutical Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Sichuan Kelun Pharmaceutical Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	23015.594	+	13439.308
	=	36,455

Sichuan Kelun Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	25872.452	+	11804.006
	=	37,676

Sichuan Kelun Pharmaceutical Co (SZSE:002422) Total Assets Explanation

Total Assets is connected with ROA %.

Sichuan Kelun Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	4104.752	/	( (36454.901	+	37676.458)	/ 2 )
	=	4104.752	/	37065.6795
	=	11.07 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Sichuan Kelun Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	6219.417	/	( (36454.901	+	37676.458)	/ 2 )
=	6219.417	/	37065.6795
=	0.17

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Sichuan Kelun Pharmaceutical Co Total Assets Related Terms

Thank you for viewing the detailed overview of Sichuan Kelun Pharmaceutical Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Sichuan Kelun Pharmaceutical Co (SZSE:002422) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sichuan Kelun Pharmaceutical Co Ltd (SZSE:002422) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.36 West Baihua Road, Qingyang District, Chengdu, CHN, 610071

Website

http://www.kelun.com

Sichuan Kelun Pharmaceutical Co Ltd is a China-based Pharmaceutical company mainly focused on the production and sales of injection products, including products for glucose injection and sodium chloride injection. It manufactures and sells high-volume injections (infusions), small-volume injections (water needles), sterile powder injections (containing powdered and freeze-dried powder). Its products include tablets, capsules, capsules, granules, oral liquids, peritoneal dialysis fluids, raw material medicines, medical packaging materials, medical instruments, and antibiotic intermediates.

Executives

Lai De Gui	Executives
Feng Hao	Directors, executives
Liu Si Chuan	Directors, executives
Wang Jing Yi	Directors, executives
Wan Yang Yu	Executives
Ge Jun You	Executives
Wu Zhong Hua	Executives
Wan Peng	Supervisors
Tan Hong Bo	Executives
Liu Ge Xin	Director
Huang Xin	Securities Affairs Representative
Ge Tao	Executives
Pan Hui	Directors, executives
Zhou Xiao Dong	Executives
Zheng Chang Yan	Supervisors

Sichuan Kelun Pharmaceutical Co (SZSE:002422) Headlines

No Headlines